Literature DB >> 27259567

Influence of hospital type on survival in stage IV colorectal cancer.

Nobuaki Hoshino1, Suguru Hasegawa2, Koya Hida2, Kenji Kawada2, Ryosuke Okamura2, Madoka Hamada3, Yoshinori Munemoto4, Yoshiharu Sakai2, Masahiko Watanabe5.   

Abstract

PURPOSE: Hospital factors along with various patient and surgeon factors are considered to affect the prognosis of colorectal cancer. Hospital volume is well known, but little is known regarding other hospital factors.
METHODS: We reviewed data on 853 patients with stage IV colorectal cancer who underwent elective palliative primary tumor resection between January 2006 and December 2007. To detect the hospital factors that could influence the prognosis of incurable colorectal cancer, the relationships between patient/hospital factors and overall survival were analyzed. Among hospital factors, hospital type (Group A: university hospital or cancer center; Group B: community hospital), hospital volume, and number of colorectal surgeons were examined.
RESULTS: In univariate analysis, Group A hospitals showed significantly better prognosis than Group B hospitals (p = 0.034), while hospital volume and number of colorectal surgeons were not associated with overall survival. After adjustment for patient factors in multivariate analysis, hospital type was significantly associated with overall survival (hazard ratio: 1.31; 95 % confidence interval: 1.05-1.63; p = 0.016). However, there was no significant difference in short-term outcomes between hospital types.
CONCLUSIONS: Hospital type was identified as a hospital factor that possibly affects the prognosis of stage IV colorectal cancer patients.

Entities:  

Keywords:  Colorectal neoplasms; Hospital factors; Stage IV; Survival

Mesh:

Year:  2016        PMID: 27259567     DOI: 10.1007/s00384-016-2611-9

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  24 in total

1.  Variation in the provision of chemotherapy for colorectal cancer.

Authors:  A McLeod
Journal:  J Epidemiol Community Health       Date:  1999-12       Impact factor: 3.710

2.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer.

Authors:  Toshiaki Watanabe; Michio Itabashi; Yasuhiro Shimada; Shinji Tanaka; Yoshinori Ito; Yoichi Ajioka; Tetsuya Hamaguchi; Ichinosuke Hyodo; Masahiro Igarashi; Hideyuki Ishida; Megumi Ishiguro; Yukihide Kanemitsu; Norihiro Kokudo; Kei Muro; Atsushi Ochiai; Masahiko Oguchi; Yasuo Ohkura; Yutaka Saito; Yoshiharu Sakai; Hideki Ueno; Takayuki Yoshino; Takahiro Fujimori; Nobuo Koinuma; Takayuki Morita; Genichi Nishimura; Yuh Sakata; Keiichi Takahashi; Hiroya Takiuchi; Osamu Tsuruta; Toshiharu Yamaguchi; Masahiro Yoshida; Naohiko Yamaguchi; Kenjiro Kotake; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2011-10-15       Impact factor: 3.402

Review 3.  Benefits from specialised cancer care.

Authors:  P Selby; C Gillis; R Haward
Journal:  Lancet       Date:  1996-08-03       Impact factor: 79.321

4.  Hospital-Level Factors Associated With Mortality After Endovascular and Open Abdominal Aortic Aneurysm Repair.

Authors:  Caitlin W Hicks; Elizabeth C Wick; Joseph K Canner; James H Black; Isibor Arhuidese; Umair Qazi; Tammam Obeid; Julie A Freischlag; Mahmoud B Malas
Journal:  JAMA Surg       Date:  2015-07       Impact factor: 14.766

Review 5.  Management of stage IV rectal cancer: palliative options.

Authors:  Sean M Ronnekleiv-Kelly; Gregory D Kennedy
Journal:  World J Gastroenterol       Date:  2011-02-21       Impact factor: 5.742

6.  A home-based exercise program to improve function, fatigue, and sleep quality in patients with Stage IV lung and colorectal cancer: a randomized controlled trial.

Authors:  Andrea L Cheville; Jenny Kollasch; Justin Vandenberg; Tiffany Shen; Axel Grothey; Gail Gamble; Jeffrey R Basford
Journal:  J Pain Symptom Manage       Date:  2012-09-24       Impact factor: 3.612

7.  Meta-analysis of survival of patients with stage IV colorectal cancer managed with surgical resection versus chemotherapy alone.

Authors:  A P Stillwell; P G Buettner; Y H Ho
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

8.  Unresectable colorectal cancer can be cured with multimodality therapy.

Authors:  Kellie L Mathis; Heidi Nelson; John H Pemberton; Michael G Haddock; Leonard L Gunderson
Journal:  Ann Surg       Date:  2008-10       Impact factor: 12.969

9.  Patient-reported quality of supportive care among patients with colorectal cancer in the Veterans Affairs Health Care System.

Authors:  Michelle van Ryn; Sean M Phelan; Neeraj K Arora; David A Haggstrom; George L Jackson; S Yousuf Zafar; Joan M Griffin; Leah L Zullig; Dawn Provenzale; Mark W Yeazel; Rahul M Jindal; Steven B Clauser
Journal:  J Clin Oncol       Date:  2014-02-03       Impact factor: 44.544

10.  Association of hospital and provider types on sickle cell disease outcomes.

Authors:  Sophia Jan; Gail Slap; Kim Smith-Whitley; Dingwei Dai; Ron Keren; David M Rubin
Journal:  Pediatrics       Date:  2013-10-28       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.